Tomoko S. Kato - Concepedia

Author

Tomoko S. Kato

Columbia University Irving Medical Center ORCID

Also Known As

Akira Funada, T Kato, T S Kato, T. Kato, T.S. Kato, Tomoko KATO, Tomoko Kato, Tomoko S Kato, Tomoko S. Kato, Tomoko Sugiyama Kato

186

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Columbia University Irving Medical Center Juntendo University Nagoya University National Cerebral and Cardiovascular Center NewYork–Presbyterian Hospital

About

Tomoko S. Kato is an author at Columbia University Irving Medical Center specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	40	2.6K
2	Public Health	13	13	914
3	Health Sciences	3	3	165
4	Allergy	2	2	48
5	Applied Physiology	1	1	11

Tomoko S. Kato

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Development of a Novel Echocardiography Ramp Test for Speed Optimization and Diagnosis of Device Thrombosis in Continuous-Flow Left Ventricular Assist Devices Nir Uriel, Kerry A. Morrison, A.R. Garan, Journal of the American College of Cardiology ThrombosisHeart FailureCardiac AnaesthesiaDevice TherapyCardiovascular Disease	2012	343
Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure Aalap Chokshi, Konstantinos Drosatos, Faisal H. Cheema, Circulation	2012	285
Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy Hideo Izawa, Toyoaki Murohara, Kohzo Nagata, Circulation	2005	263
Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive Rats Kohzo Nagata, Koji Obata, Jinglan Xu, Hypertension HypertensionHeart FailureCardiovascular PharmacologyCardiovascular FunctionMolecular Pharmacology	2006	222
Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography Tomoko S. Kato, Akiko Noda, Hideo Izawa, Circulation	2004	215
Reduced Handgrip Strength as a Marker of Frailty Predicts Clinical Outcomes in Patients With Heart Failure Undergoing Ventricular Assist Device Placement Christine Chung, Christina Wu, Meaghan Jones, Journal of Cardiac Failure Heart FailureDevice TherapyCardiovascular DiseaseMechanical Circulatory SupportHandgrip Strength	2014	189
Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system Jonathan Yang, Tomoko S. Kato, B.P. Shulman, The Journal of Heart and Lung Transplantation Heart FailureHepatologyCardiovascular DiseaseDevice TherapyLiver Physiology	2012	185
Hepatic Dysfunction in Ambulatory Patients With Heart Failure Margaret S. Kim, Tomoko S. Kato, Maryjane Farr, Journal of the American College of Cardiology Heart FailureHepatologyCardiovascular DiseaseLiver PhysiologyAcute Liver Failure	2013	162
Effects of Continuous-Flow Versus Pulsatile-Flow Left Ventricular Assist Devices on Myocardial Unloading and Remodeling Tomoko S. Kato, Aalap Chokshi, Parvati Singh, Circulation Heart Failure	2011	153
International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024 Yael Peled, Anique Ducharme, M. Kittleson, The Journal of Heart and Lung Transplantation Transplantation SurgeryTransplantationCardiovascular DiseaseMedicineOutcomes Research	2024	135

Page 1